Exercise 6: Post-mortem analysis of an under-powered randomized trial
The randomized clinical trial EOLIA1 evaluated a new treatment for severe acute respiratory distress syndrome (severe ARDS) by comparing the mortality rate after 60 days among 249 patients randomized between a control group (receiving conventional treatment, i.e. mechanical ventilation) and a treatment group receiving extracorporeal membrane oxygenation (ECMO) — the new treatment studied. A frequentist analysis of the data concluded to a Relative Risk of death of \(0.76\) in the ECMO group compared to controls (in Intention to Treat), with \(CI_{95\%} = [0.55 , 1.04]\) and the associated p-value of \(0.09\).
Goligher et al. (2019) 2 performed a Bayesian re-analysis of these data, further exploring the evidence and how it can be quantified and summarized with a Bayesian approach.
Control | ECMO | |
---|---|---|
\(n\) observed | 125 | 124 |
number of deceased at 60 days | 57 | 44 |
Write the Bayesian model used by Goligher et al. (2019).
Write the corresponding BUGS model, and save it into a
.txt
file (for instance calledgoligherBUGSmodel.txt
)First create two binary data vectors
ycontrol
andyecmo
(orycontrol
andyecmo
that are either1
or0
, using therep()
R function if you prefer the individual model), to encode the observations from the data table above. Then uses thejags.model()
andcoda.samples()
to replicate the estimation from Goligher et al. (2019) (ProTip: use the functionwindow()
to remove the burn-in observation from the output of thecoda.samples
function.)Check the convergence, and then comment the estimate results (ProTip: look at the effective sample size with the
effectiveSize()
R
function).Change to a more informative prior using a Gaussian distribution for the log(RR), centered on log(0.78) and with a standard deviation of 0.15 in the log(RR) scale (i.e. a precision of \(\approx 45\)). Comment the results. Try out other prior distributions.
Alain Combes et al. “Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome,” New England Journal of Medicine 378, no. 21 (2018): 1965–1975, doi:10.1056/NEJMoa1800385.↩︎
Ewan C. Goligher et al. “Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial,” JAMA 320, no. 21 (2018): 2251, doi:10.1001/jama.2018.14276.↩︎